Sei Investments CO Corcept Therapeutics Inc Transaction History

Sei Investments CO

$69 Billion
Q2 2024

A detailed history of Sei Investments CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Sei Investments CO holds 9,626 shares of CORT stock, worth $437,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,626

Previous 61,627 84.38%

Holding current value

$437,309

Previous $1.55 Million 79.9%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $1.15 Million - $1.79 Million	-52,001 Reduced 84.38%	9,626 $312,000
Q1 2024 May 07, 2024	BUY	$21.1 - $27.46 $877,760 - $1.14 Million	41,600 Added 207.72%	61,627 $1.55 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $433,034 - $573,657	-17,447 Reduced 46.56%	20,027 $650,000
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $439,575 - $676,270	20,008 Added 114.55%	37,474 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $6,496 - $7,620	303 Added 1.77%	17,466 $388,000
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $53,011 - $67,561	2,761 Added 19.17%	17,163 $371,000
Q4 2022 Feb 10, 2023	SELL	$19.95 - $29.96 $381,404 - $572,775	-19,118 Reduced 57.03%	14,402 $292,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $468,188 - $551,969	18,955 Added 130.14%	33,520 $859,000
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $7,399 - $10,803	427 Added 3.02%	14,565 $394,000
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $233,701 - $356,418	14,138 New	14,138 $367,000
Q1 2021 May 12, 2021	SELL	$23.49 - $30.56 $536,088 - $697,440	-22,822 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$16.78 - $27.3 $408,744 - $665,000	-24,359 Reduced 51.63%	22,822 $597,000
Q3 2020 Nov 06, 2020	SELL	$12.46 - $19.98 $364,691 - $584,794	-29,269 Reduced 38.29%	47,181 $821,000
Q2 2020 Aug 17, 2020	BUY	$11.0 - $18.26 $390,302 - $647,901	35,482 Added 86.61%	76,450 $1.29 Million
Q2 2020 Aug 11, 2020	SELL	$11.0 - $18.26 $391,402 - $649,727	-35,582 Reduced 46.48%	40,968 $524,000
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $356,539 - $495,134	35,266 Added 85.42%	76,550 $910,000
Q4 2019 Feb 06, 2020	SELL	$12.06 - $16.96 $72,335 - $101,726	-5,998 Reduced 12.69%	41,284 $500,000
Q3 2019 Nov 12, 2019	SELL	$10.41 - $14.66 $62,345 - $87,798	-5,989 Reduced 11.24%	47,282 $668,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $217,653 - $283,973	22,255 Added 71.75%	53,271 $594,000
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $215,253 - $337,152	-21,461 Reduced 40.9%	31,016 $364,000
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $2,754 - $4,194	244 Added 0.47%	52,477 $746,000
Q3 2018 Nov 08, 2018	BUY	$12.27 - $15.65 $497,082 - $634,012	40,512 Added 345.64%	52,233 $732,000
Q2 2018 Aug 03, 2018	SELL	$15.3 - $19.69 $39,137 - $50,367	-2,558 Reduced 17.91%	11,721 $184,000
Q1 2018 May 11, 2018	SELL	$14.59 - $25.5 $76,903 - $134,410	-5,271 Reduced 26.96%	14,279 $235,000
Q4 2017 Feb 08, 2018	BUY	$15.77 - $20.72 $31,350 - $41,191	1,988 Added 11.32%	19,550 $353,000
Q3 2017 Nov 06, 2017	BUY	$12.3 - $19.3 $216,012 - $338,946	17,562	17,562 $339,000

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Corcept Therapeutics Inc Transaction History